Tuesday, September 20, 2016

Hydroquinone Cream


Pronunciation: hye-droe-KWIN-own
Generic Name: Hydroquinone
Brand Name: Examples include Esoterica and Melquin


Hydroquinone Cream is used for:

Lightening freckles, age spots, and other skin discolorations associated with pregnancy, skin trauma, birth control pills, or hormone replacement therapy. It may also be used for other conditions as determined by your doctor.


Hydroquinone Cream is a skin-bleaching agent. It works by inhibiting an enzyme reaction in skin cells.


Do NOT use Hydroquinone Cream if:


  • you are allergic to any ingredient in Hydroquinone Cream

  • you are pregnant

Contact your doctor or health care provider right away if any of these apply to you.



Before using Hydroquinone Cream:


Some medical conditions may interact with Hydroquinone Cream. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are planning to become pregnant or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

Some MEDICINES MAY INTERACT with Hydroquinone Cream. However, no specific interactions with Hydroquinone Cream are known at this time.


This may not be a complete list of all interactions that may occur. Ask your health care provider if Hydroquinone Cream may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Hydroquinone Cream:


Use Hydroquinone Cream as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Before using Hydroquinone Cream for the first time, apply a small amount to an unbroken patch of skin and check in 24 hours for itching, blistering, or excessive redness or irritation. If these effects develop, contact your doctor as soon as possible and do not use Hydroquinone Cream on other areas.

  • Wash and completely dry the affected areas. Gently rub the medicine in until it is evenly distributed. Wash your hands immediately after using Hydroquinone Cream, unless your hands are part of the treated area.

  • If you miss a dose of Hydroquinone Cream, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Hydroquinone Cream.



Important safety information:


  • Protect your skin from the sun during and after the use of Hydroquinone Cream. Limit sun exposure, use a sunscreen, and wear protective clothing to cover the treated areas.

  • Hydroquinone Cream is for external use only. Avoid getting Hydroquinone Cream in your eyes, nose, or mouth, or on your lips. If you get Hydroquinone Cream in your eyes, wash them out with water and contact your doctor. If you get Hydroquinone Cream on your lips or in your nose or mouth, rinse with water.

  • Do not use Hydroquinone Cream on irritated or injured skin.

  • Do not use Hydroquinone Cream with products that contain hydrogen peroxide or benzoyl peroxide. This may cause a dark staining of your skin. The staining can be removed by stopping use of the peroxide and washing your skin with soap and water.

  • Do not use Hydroquinone Cream with other medicines containing resorcinol, phenol, or salicylic acid unless otherwise directed by your doctor.

  • Some of these products contain sulfites, which can cause allergic reactions in certain individuals (eg, asthma patients). If you have previously had allergic reactions to sulfites, contact your pharmacist to determine if the product you are taking contains sulfites.

  • Hydroquinone Cream is not recommended for use in CHILDREN younger than 12 years of age. Safety and effectiveness in this age group have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Hydroquinone Cream during pregnancy. It is unknown if Hydroquinone Cream is excreted in breast milk. If you are or will be breast-feeding while you are using Hydroquinone Cream, check with your doctor or pharmacist to discuss the risks to your baby.


Possible side effects of Hydroquinone Cream:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dryness or cracking of the skin if applied around eyes or nose; minor redness or mild burning sensation at application site.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blistering; blue-black darkening of the skin; excessive redness, stinging, or irritation.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Hydroquinone side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Hydroquinone Cream:

Store Hydroquinone Cream at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Keep Hydroquinone Cream out of the reach of children and away from pets.


General information:


  • If you have any questions about Hydroquinone Cream, please talk with your doctor, pharmacist, or other health care provider.

  • Hydroquinone Cream is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Hydroquinone Cream. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Hydroquinone resources


  • Hydroquinone Side Effects (in more detail)
  • Hydroquinone Use in Pregnancy & Breastfeeding
  • Hydroquinone Support Group
  • 2 Reviews for Hydroquinone - Add your own review/rating


Compare Hydroquinone with other medications


  • Dermatological Disorders

Hydromorphone Tablets



Pronunciation: HYE-droe-MOR-fone
Generic Name: Hydromorphone
Brand Name: Dilaudid


Hydromorphone is used for:

Treating pain in certain patients.


Hydromorphone is an opioid (narcotic) analgesic. It works by binding to certain receptors in the brain and nervous system to reduce pain.


Do NOT use Hydromorphone if:


  • you are allergic to any ingredient in Hydromorphone or any other codeine- or morphine-related medicine (eg, morphine, codeine, oxycodone)

  • you have difficult or slowed breathing, chronic obstructive pulmonary disease (COPD), or right-sided heart problems (cor pulmonale), or you are having a severe asthma attack

  • you are in labor

  • you have severe diarrhea or other bowel problems caused by antibiotics or poisoning

  • you have a brain injury or growths in the brain along with increased pressure in the brain

  • you are taking sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Hydromorphone:


Some medical conditions may interact with Hydromorphone. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of lung or breathing problems (eg, asthma, emphysema, bronchitis), seizures (eg, epilepsy), adrenal gland problems, an enlarged prostate, heart problems, low blood pressure, dehydration, low blood volume, an underactive thyroid, or urinary blockage

  • if you have severe drowsiness, a recent head injury, spinal problems, growths in the brain, or increased pressure in the brain

  • if you have liver or kidney problems, gallbladder problems, or stomach or bowel problems (eg, inflammation), or if you have had recent stomach or bowel surgery

  • if you drink alcohol regularly, have symptoms of alcohol withdrawal, or have a history of suicidal thoughts or attempts

  • if you have a personal or family history of mental or mood problems, alcohol abuse, or other substance abuse or dependence

  • if you are in poor health or shock, or will be having surgery

Some MEDICINES MAY INTERACT with Hydromorphone. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Phenothiazines (eg, chlorpromazine) because the risk of low blood pressure may be increased

  • Barbiturate anesthetics (eg, thiopental), cimetidine, or sodium oxybate (GHB) because the risk of severe drowsiness, coma, or slowed or difficult breathing may be increased

  • Agonist/antagonist analgesics (eg, pentazocine) or naltrexone because they may decrease Hydromorphone's effectiveness and withdrawal may occur

This may not be a complete list of all interactions that may occur. Ask your health care provider if Hydromorphone may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Hydromorphone:


Use Hydromorphone as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Hydromorphone may be taken with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • Hydromorphone must only be taken by mouth.

  • If you are taking Hydromorphone for persistent pain, take it on a regular schedule to help control the pain more effectively.

  • Do not change your dose or suddenly stop taking Hydromorphone without checking with your doctor.

  • If Hydromorphone is no longer needed, dispose of it as soon as possible. Ask your doctor or pharmacist how to dispose of Hydromorphone properly.

  • If you miss a dose of Hydromorphone and you are taking it regularly, take it as soon as possible. If several hours have passed or if it is nearing time for the next dose, do not double the dose to catch up, unless advised by your health care provider. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Hydromorphone.



Important safety information:


  • Hydromorphone may cause drowsiness, dizziness, blurred vision, or lightheadedness. These effects may be worse if you take it with alcohol, other opiate pain medicines, or certain other medicines. Use Hydromorphone with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you take Hydromorphone; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Hydromorphone may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Hydromorphone may be habit-forming. Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor. Misuse or abuse of Hydromorphone may cause severe side effects, including severe breathing problems, seizures, coma, and possibly death.

  • Some of these products contain sulfites. Sulfites may cause an allergic reaction in some patients (eg, asthma patients). If you have ever had an allergic reaction to sulfites, ask your pharmacist if this product has sulfites in it.

  • Constipation is a common side effect of Hydromorphone. Talk to your doctor about using laxatives or stool softeners to prevent or treat constipation while you use Hydromorphone.

  • If your pain continues or becomes worse or if you have side effects that concern you, contact your doctor.

  • Tell your doctor or dentist that you take Hydromorphone before you receive any medical or dental care, emergency care, or surgery.

  • Use Hydromorphone with caution in the ELDERLY; they may be more sensitive to its effects, especially drowsiness and breathing problems.

  • Hydromorphone should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Hydromorphone may cause harm to the fetus. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Hydromorphone while you are pregnant. Hydromorphone is found in breast milk. Do not breast-feed while taking Hydromorphone.

When used for long periods of time or at high doses, Hydromorphone may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Hydromorphone stops working well. Do not take more than prescribed.


Some people who use Hydromorphone for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction. Dependence is unlikely to be an issue in terminally ill patients where comfort is more important. If you are taking Hydromorphone regularly, do not suddenly stop taking it without checking with your doctor. WITHDRAWAL symptoms have occurred when Hydromorphone is suddenly stopped and may include anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea and vomiting; pain; rigid muscles; seeing, hearing, or feeling things that are not there; shivering or tremors; sweating; and trouble sleeping. Contact your doctor if you notice any of these symptoms after stopping Hydromorphone.



Possible side effects of Hydromorphone:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; dizziness, drowsiness; dry mouth; flushing; lightheadedness; nausea; sweating; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fainting; fast, slow, or irregular heartbeat; hallucinations; mental or mood changes; seizure; severe or persistent dizziness or drowsiness; severe or persistent headache or vomiting; shallow, slowed, or difficult breathing; tremor; trouble urinating; vision changes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Hydromorphone side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include bluish skin; chest pain; cold and clammy skin; coma; difficult or slow breathing; excessive sweating; limp muscles; nausea and vomiting; numbness of an arm or leg; pinpoint pupils; seizures; severe drowsiness or dizziness; slow or irregular heartbeat.


Proper storage of Hydromorphone:

Store Hydromorphone at 77 degrees F (25 degrees C). Store away from heat, moisture, and light. Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Do not store Hydromorphone in the bathroom. Keep Hydromorphone out of the reach of children and away from pets.


General information:


  • If you have any questions about Hydromorphone, please talk with your doctor, pharmacist, or other health care provider.

  • Hydromorphone is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Hydromorphone. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Hydromorphone resources


  • Hydromorphone Side Effects (in more detail)
  • Hydromorphone Dosage
  • Hydromorphone Use in Pregnancy & Breastfeeding
  • Drug Images
  • Hydromorphone Drug Interactions
  • Hydromorphone Support Group
  • 165 Reviews for Hydromorphone - Add your own review/rating


Compare Hydromorphone with other medications


  • Anesthetic Adjunct
  • Cough
  • Pain

Hydrocortisone/Lidocaine Cream


Pronunciation: hye-droe-KOR-ti-sone/LYE-doe-kane
Generic Name: Hydrocortisone/Lidocaine
Brand Name: Examples include AnaMantle HC and Rectacreme HC


Hydrocortisone/Lidocaine Cream is used for:

Treating pain, itching, soreness, and discomfort of the anal area due to certain conditions, such as anal fissures and hemorrhoids.


Hydrocortisone/Lidocaine Cream is an anti-inflammatory and topical anesthetic combination. It works by preventing nerves from transmitting painful impulses to the brain and decreasing inflammation around the affected area.


Do NOT use Hydrocortisone/Lidocaine Cream if:


  • you are allergic to any ingredient in Hydrocortisone/Lidocaine Cream or to similar medicines (eg, amide-type local anesthetics)

  • you have a tuberculosis or fungal infection of the skin, a herpes simplex skin infection, chickenpox, or a skin infection following smallpox vaccination

Contact your doctor or health care provider right away if any of these apply to you.



Before using Hydrocortisone/Lidocaine Cream:


Some medical conditions may interact with Hydrocortisone/Lidocaine Cream. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have had a severe allergic reaction (eg, severe rash, hives, difficulty breathing, dizziness) to any anesthetic medicine

  • if you have measles, a skin infection or other skin problems (eg, cuts, scrapes, thinning), or a herpes infection of the eye

  • if you have had any recent vaccinations or you have ever had a positive tuberculin skin test

  • if you have heart, liver, or kidney problems; diabetes; diarrhea; an infection; stomach or intestinal problems (eg, inflammation, blockage, ulcer) or have had recent stomach or intestinal surgery; esophagus problems (eg, inflammation); a colostomy; osteoporosis (weak bones); or myasthenia gravis (muscle weakness)

  • if you are very ill or weak

Some MEDICINES MAY INTERACT with Hydrocortisone/Lidocaine Cream. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Antiarrhythmics (eg, flecainide, quinidine) because the risk of their side effects may be increased by Hydrocortisone/Lidocaine Cream

This may not be a complete list of all interactions that may occur. Ask your health care provider if Hydrocortisone/Lidocaine Cream may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Hydrocortisone/Lidocaine Cream:


Use Hydrocortisone/Lidocaine Cream as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Hydrocortisone/Lidocaine Cream is for external use only. Do not get Hydrocortisone/Lidocaine Cream in your eyes, nose, or mouth. If you get Hydrocortisone/Lidocaine Cream in your eyes, rinse immediately with cool water.

  • Keep Hydrocortisone/Lidocaine Cream inside the child-resistent packaging until you are ready to use it.

  • Clean the affected area with a single-use wipe before applying Hydrocortisone/Lidocaine Cream.

  • Remove the cap from the tube and attach the applicator to the end of the tube. While holding the tube, squeeze the tube to fill the applicator until a small amount of medicine shows. Lubricate the end of the tip with the medicine. Gently insert the applicator tip into the anal area. Do NOT completely insert the applicator and tube into the anus or insert deep into the rectum. Squeeze the tube to apply the medicine to the affected areas as directed by your doctor.

  • Throw away the tube and applicator after a single use, away from children and pets. Do not reuse.

  • Do not bandage or wrap the affected area unless otherwise directed by your doctor.

  • If you miss a dose of Hydrocortisone/Lidocaine Cream, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Hydrocortisone/Lidocaine Cream.



Important safety information:


  • Hydrocortisone/Lidocaine Cream may cause harm if it is swallowed. If you may have taken it by mouth, contact your poison control center or emergency room right away.

  • Hydrocortisone/Lidocaine Cream has a corticosteroid (hydrocortisone) in it. Before you start any new medicine, check the label to see if it has a corticosteroid in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • Tell your doctor or dentist that you take Hydrocortisone/Lidocaine Cream before you receive any medical or dental care, emergency care, or surgery.

  • Hydrocortisone/Lidocaine Cream may cause a numbing effect at the application site. Do not scratch, rub, or expose the area to extreme hot or cold temperature until the numbness is gone.

  • If you use topical products too often, your condition may become worse.

  • Do NOT use more than the recommended dose, apply more often, or use for longer than prescribed without checking with your doctor.

  • Use Hydrocortisone/Lidocaine Cream with caution in the ELDERLY; they may be more sensitive to its effects.

  • Hydrocortisone/Lidocaine Cream should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • Corticosteroids may affect growth rate in CHILDREN and teenagers in some cases. They may need regular growth checks while they use Hydrocortisone/Lidocaine Cream.

  • PREGNANCY and BREAST-FEEDING: It is not known if Hydrocortisone/Lidocaine Cream can cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Hydrocortisone/Lidocaine Cream while you are pregnant. It is not known if Hydrocortisone/Lidocaine Cream is found in breast milk. If you are or will be breast-feeding while you use Hydrocortisone/Lidocaine Cream, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Hydrocortisone/Lidocaine Cream:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Redness or temporary stinging, burning, or lightening of skin; temporary numbness at the application site.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); infection; persistent or severe irritation; swelling.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Hydrocortisone/Lidocaine side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include increased thirst or urination; muscle weakness; unusual weight gain, especially in the face.


Proper storage of Hydrocortisone/Lidocaine Cream:

Store Hydrocortisone/Lidocaine Cream at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Protect from freezing. Store away from heat and light. Do not store in the bathroom. Keep Hydrocortisone/Lidocaine Cream out of the reach of children and away from pets.


General information:


  • If you have any questions about Hydrocortisone/Lidocaine Cream, please talk with your doctor, pharmacist, or other health care provider.

  • Hydrocortisone/Lidocaine Cream is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Hydrocortisone/Lidocaine Cream. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Hydrocortisone/Lidocaine resources


  • Hydrocortisone/Lidocaine Side Effects (in more detail)
  • Hydrocortisone/Lidocaine Use in Pregnancy & Breastfeeding
  • Hydrocortisone/Lidocaine Drug Interactions
  • Hydrocortisone/Lidocaine Support Group
  • 1 Review for Hydrocortisone/Lidocaine - Add your own review/rating


Compare Hydrocortisone/Lidocaine with other medications


  • Hemorrhoids
  • Pruritus

Hydroxocobalamin




Hydroxocobalamin INJECTION USP

Rx only

Hydroxocobalamin Description


Hydroxocobalamin injection is a sterile solution of Hydroxocobalamin for intramuscular administration.


Each mL contains: Hydroxocobalamin Acetate equivalent to 1000 mcg Hydroxocobalamin, Sodium Acetate Anhydrous 0.2 mg, Glacial Acetic Acid 0.442 mg, Sodium Chloride 8.2 mg, with Methylparaben 1.5 mg and Propylparaben 0.2 mg as preservatives, in Water for Injection q.s. Additional Glacial Acetic Acid and/or Sodium Acetate may have been used to adjust pH. pH range is 3.5 to 5.0.


Hydroxocobalamin appears as dark red orthorhombic needles or as an amorphous or crystalline red powder. It is very hygroscopic in the anhydrous form, and moderately soluble in water. It has a molecular weight of 1346.37. The vitamin B12 coenzymes are very unstable in light. Hydroxocobalamin shares the cobalamin molecular structure with cyanocobalamin.


The chemical name is α-(5,6-dimethylbenzimidazoly) hydroxocobamide. The empirical formula is C62H89CoN13O15P and its structural formula is:



The cobalt content is 4.34%.



Hydroxocobalamin - Clinical Pharmacology


Vitamin B12 is essential to growth, cell reproduction, hematopoiesis, nucleoprotein and myelin synthesis.


Fifty percent of the administered dose of Hydroxocobalamin disappears from the injection site in 2.5 hours. Hydroxocobalamin is bound to plasma proteins and stored in the liver. It is excreted in the bile and undergoes some enterohepatic recycling. Within 72 hours after injection of 500 to 1000 mcg of Hydroxocobalamin, 16 to 66 percent of the injected dose may appear in the urine. The major portion is excreted within the first 24 hours.



Indications and Usage for Hydroxocobalamin



  1. Pernicious anemia, both uncomplicated and accompanied by nervous system involvement.




  2. Dietary deficiency of Vitamin B12, occurring in strict vegetarians and in their breast-fed infants. (Isolated vitamin B12 deficiency is very rare).




  3. Malabsorption of vitamin B12, resulting from structural or functional damage to the stomach, where intrinsic factor is secreted or to the ileum, where intrinsic factor facilitates vitamin B12 absorption. These conditions include tropical sprue, and nontropical sprue (idiopathic steatorrhea, gluten-induced enteropathy). Folate deficiency in these patients is usually more severe than vitamin B12 deficiency.




  4. Inadequate secretion of intrinsic factor, resulting from lesions that destroy the gastric mucosa (ingestion of corrosives, extensive neoplasia), and a number of conditions associated with a variable degree of gastric atrophy (such as multiple sclerosis, certain endocrine disorders, iron deficiency, and subtotal gastrectomy). Total gastrectomy always produces vitamin B12 deficiency.


    Structural lesions leading to vitamin B12 deficiency include regional ileitis, ileal resections, malignancies, etc.




  5. Competition for Vitamin B12 by intestinal parasites or bacteria.


    The fish tapeworm (Diphyilobothrium latum) absorbs huge quantities of vitamin B12 and infested patients often have associated gastric atrophy. The blind-loop syndrome may produce deficiency of Vitamin B12 or folate.




  6. Inadequate utilization of vitamin B12. This may occur if antimetabolites for the vitamin are employed in the treatment of neoplasia.




  7. For the Schilling Test.




CONTRAINDICATION


Hypersensitivity to any component of this medication.



Warnings


Avoid the intravenous route.


Folic acid is not a substitute for vitamin B12 although it may improve vitamin B12 deficient megaloblastic anemia. Exclusive use of folic acid in treating vitamin B12 deficient megaloblastic anemia could result in progressive and irreversible neurologic damage.


Blunted or impeded therapeutic response to vitamin B12 may be due to such conditions as infection, uremia, drugs having bone marrow suppressant properties such as chloramphenicol, and concurrent iron or folic acid deficiency.



Precautions



General


The validity of diagnostic vitamin B12 or folic acid blood assays could be compromised by medications, and this should be considered before relying on such tests for therapy.


Vitamin B12 is not a substitute for folic acid and since it might improve folic acid deficient megaloblastic anemia, indiscriminate use of vitamin B12 could mask the true diagnosis.


Hypokalemia and thrombocytosis could occur upon conversion of severe megaloblastic to normal erythropoiesis with B12 therapy. Therefore, serum potassium levels and the platelet count should be monitored carefully during therapy.


Vitamin B12 deficiency may suppress the signs of polycythemia vera. Treatment with vitamin B12 may unmask this condition.



Carcinogenesis, Mutagenesis, Impairment of Fertility


Studies of carcinogenicity, mutagenesis, or impairment of fertility have not been performed with Hydroxocobalamin.



Pregnancy


Teratogenic Effects: Pregnancy Category C: Animal reproduction studies have not been conducted with Hydroxocobalamin. It is also not known whether Hydroxocobalamin can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Hydroxocobalamin should be given to a pregnant woman only if clearly needed.



Adverse Reactions


Mild transient diarrhea, itching, transitory exanthema, feeling of swelling of entire body, and anaphylaxis.


A few patients may experience pain after injection of Hydroxocobalamin.



Overdosage


The intravenous LD50 of Hydroxocobalamin in mice is greater than 50 mL/kg.



Hydroxocobalamin Dosage and Administration


Protect from light.


Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.


Hydroxocobalamin injection should be given only intramuscularly.


In patients with Addisonian Pernicious Anemia, parenteral therapy with vitamin B12 is the recommended method of treatment and will be required for the remainder of the patient’s life. Oral therapy is not dependable. In other patients with vitamin B12 deficiency, the duration of therapy and route of administration will depend upon the cause and whether or not it is reversible.


Confirmatory diagnostic studies should be performed prior to initiating therapy, if possible, and the patient should be followed with appropriate studies to demonstrate hematologic improvement (Hgb, hematocrit, RBC, reticulocyte count). A diagnostic trial utilizing physiologic doses of vitamin B12 (1 mcg daily) and observing daily reticulocyte counts after establishing a baseline may also be performed. The observation of reticulocytosis which usually occurs between the third and tenth day of therapy confirms the diagnosis of vitamin B12 deficiency.


In seriously ill patients it may be advisable to administer both vitamin B12 and folic acid while awaiting the results of distinguishing laboratory studies. It is not necessary to withhold vitamin B12 therapy until the precise cause of B12 deficiency is established since absorption studies can be performed at any time.


Serum potassium should be closely observed the first 48 hours and potassium should be administered if necessary.



Treatment of Vitamin B12 Deficiency


Thirty mcg daily for 5 to 10 days followed by 100 to 200 mcg monthly injected intramuscularly. If the patient is critically ill, or has neurologic disease, an infectious disease or hyperthyroidism, considerably higher doses may be indicated. However, current data indicate that the optimum obtainable neurologic response may be expected with a dosage of vitamin B12 sufficient to produce good hematologic response. Children may be given a total of 1 to 5 mg over a period of 2 or more weeks in doses of 100 mcg, then 30 to 50 mcg every 4 weeks for maintenance.


Patients who have normal intestinal absorption may be treated with an oral therapeutic multivitamin preparation, containing 15 mcg vitamin B12 daily.



Schilling Test


The flushing dose is 1000 mcg.



How is Hydroxocobalamin Supplied


Hydroxocobalamin Injection USP, 1000 mcg/mL is available in a 30 mL multiple dose vial, individually boxed.



Storage


Store at 20°-25°C (68°-77°F). [See USP controlled room temperature.] PROTECT FROM LIGHT.


Literature revised: July 2010


Product No.: 0208-30


Manufactured by:

Hikma Farmaceutica (Portugal)

S.A. 2705-906 Terrugem SNT, Portugal


Distributed by:

Watson Pharma, Inc.

Corona, CA 92880 USA                        PIN229 - WAT / 1



PRINCIPAL DISPLAY PANEL


NDC 0591-2888-30

30 mL Sterile Multiple Dose Vial

Hydroxocobalamin

Injection USP


30,000 mcg/30 mL

(1,000 mcg/mL)


FOR INTRAMUSCULAR

USE ONLY


Watson            Rx only


Each mL contains:

Hydroxocobalamin Acetate equivalent to 1000 mcg Hydroxocobalamin,

Sodium Acetate Anhydrous 0.2 mg, Glacial Acetic Acid 0.442 mg,

Sodium Chloride 8.2 mg, with Methylparaben 1.5 mg and Propylparaben 0.2 mg

as preservatives, in Water for Injection q.s. Additional Glacial Acetic Acid

and/or Sodium Acetate may have been used to adjust pH.

pH range is 3.5 to 5.0.


Usual dosage: See package insert for full information.


Store at 20ºC-25ºC (68º-77ºF). [See USP controlled room temperature.]


PROTECT FROM LIGHT.


PBX351-WAT/1


Manufactured by:

Hikma Farmaceutica (Portugal)

S.A. 2705-906 Terrugem SNT,

Portugal


Distributed by:

Watson Pharma, Inc.

Corona, CA 92880 USA









Hydroxocobalamin 
Hydroxocobalamin  injection, solution










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)0591-2888
Route of AdministrationINTRAMUSCULARDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Hydroxocobalamin ACETATE (Hydroxocobalamin)Hydroxocobalamin ACETATE1000 ug  in 1 mL
















Inactive Ingredients
Ingredient NameStrength
SODIUM ACETATE ANHYDROUS0.2 mg  in 1 mL
ACETIC ACID0.442 mg  in 1 mL
SODIUM CHLORIDE8.2 mg  in 1 mL
METHYLPARABEN1.5 mg  in 1 mL
PROPYLPARABEN0.2 mg  in 1 mL
WATER 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
10591-2888-301 VIAL In 1 CARTONcontains a VIAL, MULTI-DOSE
130 mL In 1 VIAL, MULTI-DOSEThis package is contained within the CARTON (0591-2888-30)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA08599811/12/2010


Labeler - Watson Laboratories, Inc. (966714656)









Establishment
NameAddressID/FEIOperations
Hikma Farmaceutica452742943ANALYSIS, LABEL, MANUFACTURE, PACK
Revised: 08/2011Watson Laboratories, Inc.

More Hydroxocobalamin resources


  • Hydroxocobalamin Side Effects (in more detail)
  • Hydroxocobalamin Use in Pregnancy & Breastfeeding
  • Hydroxocobalamin Drug Interactions
  • Hydroxocobalamin Support Group
  • 0 Reviews for Hydroxocobalamin - Add your own review/rating


  • Hydroxocobalamin Professional Patient Advice (Wolters Kluwer)

  • Hydroxocobalamin MedFacts Consumer Leaflet (Wolters Kluwer)

  • Cyanokit Kit MedFacts Consumer Leaflet (Wolters Kluwer)

  • Cyanokit Consumer Overview



Compare Hydroxocobalamin with other medications


  • Cyanide Poisoning
  • Schilling Test
  • Transcobalamin II Deficiency
  • Vitamin B12 Deficiency

Hydromorphone High-Potency



Pronunciation: HYE-droe-MOR-fone
Generic Name: Hydromorphone High-Potency
Brand Name: Dilaudid-HP


Hydromorphone High-Potency is used for:

Treating moderate to severe pain in narcotic-tolerant patients who require larger than usual doses to provide adequate pain relief.


Hydromorphone High-Potency is an opioid (narcotic) analgesic. It works by binding to certain receptors in the brain and nervous system to reduce pain.


Do NOT use Hydromorphone High-Potency if:


  • you are allergic to any ingredient in Hydromorphone High-Potency or any other codeine- or morphine-related medicine (eg, morphine, codeine, oxycodone)

  • you are NOT already receiving large amounts of injectable narcotics

  • you have difficult or slowed breathing, chronic obstructive pulmonary disease (COPD), or right-sided heart problems (cor pulmonale), or you are having a severe asthma attack

  • you are in labor

  • you have severe diarrhea or other bowel problems caused by antibiotics or poisoning

  • you have a brain injury or growths in the brain along with increased pressure in the brain

  • you are taking sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Hydromorphone High-Potency:


Some medical conditions may interact with Hydromorphone High-Potency. Tell your health care provider if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you are allergic to latex

  • if you have a history of lung or breathing problems (eg, asthma, emphysema, bronchitis), seizures (eg, epilepsy), adrenal gland problems, an enlarged prostate, heart problems, low blood pressure, dehydration, low blood volume, an underactive thyroid, or urinary blockage

  • if you have severe drowsiness, a recent head injury, spinal problems, growths in the brain, or increased pressure in the brain

  • if you have liver or kidney problems, gallbladder problems, or stomach or bowel problems (eg, inflammation), or if you have had recent stomach or bowel surgery

  • if you drink alcohol regularly, have symptoms of alcohol withdrawal, or have a history of suicidal thoughts or attempts

  • if you have a personal or family history of mental or mood problems, alcohol abuse, or other substance abuse or dependence

  • if you are in poor health or shock, or will be having surgery

Some MEDICINES MAY INTERACT with Hydromorphone High-Potency. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Phenothiazines (eg, chlorpromazine) because the risk of low blood pressure may be increased

  • Barbiturate anesthetics (eg, thiopental), cimetidine, or sodium oxybate (GHB) because the risk of severe drowsiness, coma, or slowed or difficult breathing may be increased

  • Agonist/antagonist analgesics (eg, pentazocine) or naltrexone because they may decrease Hydromorphone High-Potency's effectiveness and withdrawal may occur

This may not be a complete list of all interactions that may occur. Ask your health care provider if Hydromorphone High-Potency may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Hydromorphone High-Potency:


Use Hydromorphone High-Potency as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Hydromorphone High-Potency is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using Hydromorphone High-Potency at home, a health care provider will teach you how to use it. Be sure you understand how to use Hydromorphone High-Potency. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.

  • Do not use Hydromorphone High-Potency if it is cloudy or discolored, or if the vial is cracked or damaged.

  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.

  • If you are taking Hydromorphone High-Potency for persistent pain, take it on a regular schedule to help control the pain more effectively.

  • Do not change your dose or suddenly stop taking Hydromorphone High-Potency without checking with your doctor.

  • If Hydromorphone High-Potency is no longer needed, dispose of it as soon as possible. Ask your doctor or pharmacist how to dispose of Hydromorphone High-Potency properly.

  • If you miss a dose of Hydromorphone High-Potency and you are taking it regularly, take it as soon as possible. If several hours have passed or if it is nearing time for the next dose, do not double the dose to catch up, unless advised by your health care provider. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Hydromorphone High-Potency.



Important safety information:


  • Hydromorphone High-Potency may cause drowsiness, dizziness, blurred vision, or lightheadedness. These effects may be worse if you take it with alcohol, other opiate pain medicines, or certain other medicines. Use Hydromorphone High-Potency with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you take Hydromorphone High-Potency; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Hydromorphone High-Potency may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • This product contains a very large amount of hydromorphone. Do not confuse this product with other injectable forms of hydromorphone. If you have any questions about whether you should use this product or another injectable form of hydromorphone, contact your doctor or other health care provider.

  • Hydromorphone High-Potency may be habit-forming. Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor. Misuse or abuse of Hydromorphone High-Potency may cause severe side effects, including severe breathing problems, seizures, coma, and possibly death.

  • Constipation is a common side effect of Hydromorphone High-Potency. Talk to your doctor about using laxatives or stool softeners to prevent or treat constipation while you use Hydromorphone High-Potency.

  • If your pain continues or becomes worse or if you have side effects that concern you, contact your doctor.

  • Tell your doctor or dentist that you take Hydromorphone High-Potency before you receive any medical or dental care, emergency care, or surgery.

  • Use Hydromorphone High-Potency with caution in the ELDERLY; they may be more sensitive to its effects, especially drowsiness and breathing problems.

  • Hydromorphone High-Potency should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Hydromorphone High-Potency may cause harm to the fetus. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Hydromorphone High-Potency while you are pregnant. Hydromorphone High-Potency is found in breast milk. Do not breast-feed while taking Hydromorphone High-Potency.

When used for long periods of time or at high doses, Hydromorphone High-Potency may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Hydromorphone High-Potency stops working well. Do not take more than prescribed.


Some people who use Hydromorphone High-Potency for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction. Dependence is unlikely to be an issue in terminally ill patients where comfort is more important. If you are taking Hydromorphone High-Potency regularly, do not suddenly stop taking it without checking with your doctor. WITHDRAWAL symptoms have occurred when Hydromorphone High-Potency is suddenly stopped and may include anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea and vomiting; pain; rigid muscles; seeing, hearing, or feeling things that are not there; shivering or tremors; sweating; and trouble sleeping. Contact your doctor if you notice any of these symptoms after stopping Hydromorphone High-Potency.



Possible side effects of Hydromorphone High-Potency:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; dizziness, drowsiness; dry mouth; flushing; lightheadedness; nausea; sweating; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fainting; fast, slow, or irregular heartbeat; hallucinations; mental or mood changes; seizure; severe or persistent dizziness or drowsiness; severe or persistent headache or vomiting; shallow, slowed, or difficult breathing; tremor; trouble urinating; vision changes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Hydromorphone High-Potency side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include bluish skin; chest pain; cold and clammy skin; coma; difficult or slow breathing; excessive sweating; limp muscles; nausea and vomiting; numbness of an arm or leg; pinpoint pupils; seizures; severe drowsiness or dizziness; slow or irregular heartbeat.


Proper storage of Hydromorphone High-Potency:

Store Hydromorphone High-Potency at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Do not store Hydromorphone High-Potency in the bathroom. Keep Hydromorphone High-Potency out of the reach of children and away from pets.


General information:


  • If you have any questions about Hydromorphone High-Potency, please talk with your doctor, pharmacist, or other health care provider.

  • Hydromorphone High-Potency is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Hydromorphone High-Potency. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Hydromorphone High-Potency resources


  • Hydromorphone High-Potency Side Effects (in more detail)
  • Hydromorphone High-Potency Use in Pregnancy & Breastfeeding
  • Drug Images
  • Hydromorphone High-Potency Drug Interactions
  • Hydromorphone High-Potency Support Group
  • 165 Reviews for Hydromorphone High-Potency - Add your own review/rating


Compare Hydromorphone High-Potency with other medications


  • Anesthetic Adjunct
  • Cough
  • Pain

Hydroquinone


Class: Depigmenting Agents
ATC Class: D11AX11
VA Class: DE900
Chemical Name: 1,4 p-dihydroxybenzene
Molecular Formula: C6H6O2
CAS Number: 123-31-9
Brands: Aclaro PD, Alphaquin HP, Claripel, Eldopaque Forte, Eldoquin Forte, EpiQuin Micro, Esoterica, Esoterica Regular, Glyquin XM, Lustra, Lustra-Ultra, Melquin, Melpaque HP, Melquin, Nuquin HP, Solaquin, Tri-Luma

Introduction

Depigmenting agent; structurally related to monobenzone.a h s


Uses for Hydroquinone


Hyperpigmentation


Used to reduce hyperpigmentation in conditions such as freckling (ephelides), inactive chloasma, melasma, generalized and senile lentigo, and other unwanted areas of melanin hyperpigmentation.a b m


Used for gradual treatment of ultraviolet-induced dyschromia and skin discoloration resulting from the use of oral contraceptives, pregnancy, hormone replacement therapy, or skin trauma.p s


Most clinicians consider hydroquinone to be useful in some patients with hyperpigmentation in which a large excess of melanin is not being produced.a


Has been used to reduce hyperpigmentation caused by photosensitization associated with inflammation or with the use of certain perfumes.a


Used in combination with fluocinolone and tretinoin for short-term and intermittent long-term treatment of moderate to severe melasma.q


Hydroquinone Dosage and Administration


General



  • Depigmentation varies among patients in completeness, time of onset, and duration; rarely completely reduces hyperpigmentation and some patients exhibit no response to the drug.a




  • May require 1–4 months for depigmentation effects to occur.a Following discontinuance of hydroquinone, depigmentation effects usually persist for 2–6 months.a




  • Avoid unnecessary exposure to sunlight during and after therapy.a b h p s




  • Prior to initiating therapy, assess the risk of irritation or allergic reactions by applying a small amount of hydroquinone preparation to an area of unbroken skin.a b h m p s After 24 hours, examine test site; discontinue treatment if itching, vesicle formation, or excessive inflammation occurs; however, minor redness is not a contraindication for further treatment.a b h p s



Administration


Topical Administration


Apply topically to the skin as a cream, gel, emulsion, or solution.a b m p q s (See Sensitivity Reactions under Cautions.)


Limit application to an area equal to that of the face and neck or hands and arms.a s


For dermatologic use only; avoid contact with eyes.a b q s If such contact occurs, flush the affected eye(s) with copious amounts of water and contact a clinician.b


Not for oral administration.a


Apply hydroquinone cream, gel, emulsion, or solution (with or without sunscreens) uniformly to pigmented area and rub into skin.a b p s Do not rub cream containing opaque sunblocking agents (e.g., talc) into the skin.b h


If hydroquinone preparations without sunscreen agents are applied during the daytime, use sunscreen agents and/or protective clothing to minimize exposure and prevent repigmentation of treated areas; alternatively, apply these preparations only at night.a b h p q


Gently wash face and neck with mild soap, rinse, and pat dry before applying fixed-combination hydroquinone, fluocinolone, and tretinoin cream to affected area(s).q


Apply a small amount of fixed-combination hydroquinone, fluocinolone, and tretinoin cream to affected area(s), including about ½ inch of normal skin surrounding each lesion.q Rub lightly and uniformly into the skin.q Do not use occlusive dressing.q


Dosage


When the desired degree of depigmentation is obtained, apply only as often as needed to maintain depigmentation.a


Pediatric Patients


Hyperpigmentation

Topical

Adolescents >12 years of age: Apply hydroquinone cream, emulsion, gel, or solution (with or without sunscreens) uniformly to pigmented area(s) and rub in well twice daily, in the morning and evening.a b p s


If improvement does not occur after 2 months of treatment, discontinue the drug.b p s


Adults


Hyperpigmentation

Topical

Hydroquinone cream, emulsion, gel, or solution (with or without sunscreens): Apply uniformly to pigmented area(s) and rub in well twice daily, in the morning and evening or as directed by a clinician.a b h p s


Hydroquinone cream with opaque sunblock: Apply uniformly to the pigmented area(s) twice daily, in the morning and evening; do not rub into affected area(s).b h


If improvement does not occur after 2 months of treatment, discontinue the drug.b p


Melasma

Topical

Fixed-combination hydroquinone, fluocinolone, and tretinoin cream: Apply a thin layer uniformly to the affected area(s) once daily, in the evening, at least 30 minutes before bedtime.q Continue daily for as long as the melasma lesions persist.q Discontinue treatment when melasma resolves.q


If melasma reoccurs, repeat treatment until condition resolves.q


Prescribing Limits


Pediatric Patients


Hyperpigmentation

Topical

Adolescents >12 years of age: Maximum 2 months of therapy if no improvement is seen.b


Adults


Hyperpigmentation

Topical

Maximum 2 months of therapy if no improvement is seen.b p s


Melasma

Topical

Fixed-combination hydroquinone, fluocinolone, and tretinoin cream has been safely administered for cumulative ≥180 days.q


Special Populations


Geriatric Patients


Clinical studies of 4% hydroquinone cream did not include sufficient number of patients ≥65 years of age to determine whether they respond differently from younger patients. In general, dosage selection for geriatric patients should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, and/or cardiac function and of concomitant disease and drug therapy.


Cautions for Hydroquinone


Contraindications



  • History of sensitivity or allergic reaction to hydroquinone or any ingredient in the formulation.a b p q s



Warnings/Precautions


Warnings


Cosmetic Effects

May produce undesired cosmetic effects (e.g., excessive skin bleaching)q if not used as directed.a b p s Clinician should be familiar with the use, adverse effects, precautions, and contraindications before prescribing or dispensing the drug.a p s


Exposure to Sunlight or Ultraviolet Light

Exposure to sunlight or ultraviolet light may cause repigmentation of bleached areas.a b h p q Avoid unnecessary exposure to sunlight during and after therapy.a b h p s


Sunscreen agents and/or protective clothing recommended if preparations which do not contain sunscreen are applied during the daytime.a b h p q s Preparations containing sunscreen may provide sufficient protection from sunlight.a b h


After reduction of hyperpigmentation and during maintenance therapy, continue the use of sunscreen agents and/or protective clothing.a b h


Sensitivity Reactions


Sulfite Sensitivity

Some formulations contain sulfites, which may cause allergic-type reactions (including anaphylaxis and life-threatening or less severe asthmatic episodes) in certain susceptible individuals.y z aa bb cc dd ee ff


Other Sensitivity Reactions

Contact dermatitis reported.b h p q s If contact dermatitis occurs, discontinue immediately and contact a clinician.p q s


Major Toxicities


Rarely, ochronosis (gradual blue-black darkening of the skin) and colloid milium reported with chronic use (up to 8 years) of 5% hydroquinone cream. a o p q If affected skin changes to a blue-black color, discontinue immediately and contact a clinician.p q


General Precautions


Topical Use

For external use only.b Notfor topical application in the eyes, ears, or mouth;a b p to cut, abraded,m or sunburned skin; after shaving or using a depilatory agent; or over miliaria rubra (prickly heat).a


Dermatologic Effects

Possible local skin irritation (e.g., burning, stinging, mild erythema).a h Dryness and fissuring of paranasal and infraorbital areas reported.a b


Use of Fixed Combinations

When hydroquinone is used in fixed combination with topical sunscreens (e.g., dioxybenzone, oxybenzone, and padimate), fluocinolone, or retinoids (e.g., tretinoin), consider the cautions, precautions, and contraindications associated with these agents.b h p q


Specific Populations


Pregnancy

Category C.b


Lactation

Not known if topical hydroquinone is distributed into milk.a b Caution advised if topical hydroquinone is used.a b


Pediatric Use

Safety and efficacy of hydroquinone preparations not established in children <12 years of age.a b


Safety and efficacy of the fixed-combination hydroquinone, fluocinolone, and tretinoin cream not established in pediatric patients of any age.q


Common Adverse Effects


Mild skin irritation and sensitization (e.g., burning, erythema, stinging).a h


Hydroquinone Pharmacokinetics


Absorption


Duration


Depigmentation effects usually persist for 2–6 months following discontinuance of therapy.a


Stability


Storage


Topical


Manufacturer states that a slight darkening of hydroquinone preparation(s) is normal and will not affect potency.b


Cream, Gel, Emulsion, or Solution

Tight, light-resistant containersa b at 25°C (may be exposed to 15–30°C).h p s


Combination (Hydroquinone 4%, Fluocinolone acetonide 0.01%, and Tretinoin 0.05%) Cream

Tight, light-resistant containers at 20–25°C.q Do not freeze.q


ActionsActions



  • May produce a reversible skin depigmentation by inhibiting the enzymatic oxidation of tyrosine to 3, 4-dihydroxyphenylalanine (DOPA) and suppressing other melanocyte metabolic processes.b p q s




  • Increases the excretion of new melanin while existing melanin is lost during the normal sloughing of the stratum corneum.a




  • May prevent melanin production; however, does not cause destruction of melanocytes or permanent depigmentation.a



Advice to Patients



  • Importance of advising patients that topical hydroquinone is a bleaching agent and should not be used for the prevention of sunburn.a




  • Importance of avoiding contact with eyes.a b s If ocular contact occurs, rinse eye(s) promptly and thoroughly with water.b




  • Importance of advising patients that a bitter taste and an antiseptic effect may occur if hydroquinone is applied to lips.b




  • Importance of keeping hydroquinone preparations out of the reach of children.b h p




  • Importance of using sunscreen products (SPF ≥15)p and wearing protective clothing over treated areas.a b h q s Avoid exposure to sunlight, sunlamp, or ultraviolet light during and after treatment.p q




  • Importance of discontinuing drug and informing clinician if an allergic or hypersensitivity (e.g., contact dermatitis) reaction occurs.b h m q




  • Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.b q s




  • Importance of patients informing clinician of existing or contemplated concomitant therapy, including prescription and OTC drugs.m q




  • Importance of informing patients of other important precautionary information.q (See Cautions.)



Preparations


Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.


* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name




































































Hydroquinone

Routes



Dosage Forms



Strengths



Brand Names



Manufacturer



Bulk



Powder*



Topical



Cream



2%



Esoterica Regular (with parabens, propylene glycol, and sodium bisulfite)



Medicis



4%



Aclaro PD (with benzyl alcohol and propylene glycol)



Johnson & Johnson



Eldopaque Forte (with propylene glycol and sodium metabisulfite in an opaque base)



Valeant



Eldoquin Forte (with propylene glycol, propylparaben, and sodium metabisulfite)



Valeant



EpiQuin Micro (with benzyl alcohol, methylparaben, retinol 0.15%, and sodium metabisulfite in a polymeric system)



SkinMedica



Hydroquinone Cream (with parabens, propylene glycol, and sodium metabisulfite)



Ethex



Lustra (with benzyl alcohol and sodium metabisulfite)



Taro



Lustra-Ultra (with parabens, propylene glycol, retinol 0.3%, and sodium metabisulfite)



Taro



Melpaque HP (with parabens, propylene glycol, and sodium metabisulfite in an opaque talc base)



Stratus



Melquin HP (with propylene glycol and sodium metabisulfite)



Stratus



Solution



3%



Melquin-3 (with SD alcohol 45%, isopropyl alcohol 4%, and propylene glycol)



Stratus














































































Hydroquinone Combinations

Routes



Dosage Forms



Strengths



Brand Names



Manufacturer



Topical



Cream



2% with Benzophenone-3 2.5% and Octyl Dimethyl 3.3%



Esoterica Daytime with Moisturizer (with parabens, propylene glycol, and sodium bisulfite)



Medicis



Esoterica Daytime Sunscreen (with parabens, propylene glycol, and sodium bisulfite)



Medicis



Esoterica Nighttime with Moisturizer (with parabens, propylene glycol, and sodium bisulfite)



Medicis



4% with Avobenzone 3% and Octinoxate 7.5%



Claripel Cream with Sunscreens (with parabens, propylene glycol, and sodium metabisulfite)



Stiefel



4% with Avobenzone 3%, Oxybenzone 4%, and Octocrylene 8%



Glyquin XM (with methylparaben and propylene glycol)



Valeant



4% with Benzophenone-3 5% and Octyl Methoxycinnamate 7.5%



Alphaquin HP (with propylene glycol and sodium metabisulfite)



Stratus



4% with Dioxybenzone 3%, Oxybenzone 2%, and Padimate O 8%



Hydroquinone Cream with Sunscreens (with parabens, propylene glycol, and sodium metabisulfite)



Ethex



Hydroquinone Cream with Sunscreens (with propylene glycol and sodium metabisulfite)



Perrigo



Nuquin HP (with propylene glycol and sodium metabisulfite)



Stratus



Solaquin Forte (with propylene glycol and sodium metabisulfite)



Valeant



4% with Fluocinolone Acetonide 0.01% and Tretinoin 0.05%



Tri-Luma (with sodium metabisulfite)



Galderma



Gel



4% with Dioxybenzone 3% and Padimate O 5%



Hydroquinone Forte Gel (with propylene glycol and sodium metabisulfite)



Perrigo



Nuquin HP (with alcohol, propylene glycol, and sodium metabisulfite)



Stratus



Solaquin Forte (with propylene glycol and sodium metabisulfite)



Valeant



Disclaimer

This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.


The American Society of Health-System Pharmacists, Inc. and Drugs.com represent that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. and Drugs.com make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. and Drugs.com do not endorse or recommend the use of any drug. The information is not a substitute for medical care.

AHFS Drug Information. © Copyright, 1959-2011, Selected Revisions July 2008. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.




References



a. AHFS Drug Information 2007. McEvoy GK, ed. Hydroquinone. Bethesda, MD: American Society of Health-System Pharmacists; 2007: 3551-2.



b. Stratus Pharmaceuticals. Alphaquin HP (hydroquinone 4%) cream product information. Miami, FL. 2007



h. ICN Pharmaceuticals. Eldoquin Forte (hydroquinone 4%) cream, Eldopaque Forte(hydroquinone 4% with sun block) cream, Solaquin Forte (hydroquinone 4% with sunscreens, SPF 17) cream and Solaquin Forte (hydroquinone 4% with sunscreens) gel product information. Costa Mesa, CA;1998 Sept.



m. Medicis. Esoterica (hydroquinone USP, 2%) cream product information. Phoenix, AZ.



o. Food and Drug Administration. Skin Bleaching Drug Products For Over-the-Counter Human Use. Proposed Rule. [21 CFR Part 310] Fed Regist. 2006. 71:167: 51146-54.



p. SkinMedica. EpiQuin Micro (hydroquinone 4% and retinol) skin bleaching moisturizing topical cream prescribing information. 2003 Sept.



q. Galderma Laboratories. TRI-LUMA(fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) cream prescribing information. Fort Worth, TX; 2003 Dec.



s. JSJ Pharmaceuticals. Aclaro PD (hydroquinone 4%) bioadhesive emulsion product information. Charleston, SC; 2007 Jan.



t. JSJ Pharmaceuticals. Charleston, SC: Personal communication.



y. Food and Drug Administration. Sulfites in foods and drugs. FDA Drug Bull. 1983; 13:12. [PubMed 6604672]



z. Sogn D. The ubiquitous sulfites. JAMA. 1984; 251:2986 7. Editorial. [IDIS 185969] [PubMed 6716628]



aa. Koepke JW, Christopher KL, Chai H et al. Dose dependent bronchospasm from sulfites in isoetharine. JAMA. 1984; 251:2982 3. [IDIS 185966] [PubMed 6716626]



bb. Twarog FJ, Leung DYM. Anaphylaxis to a component of isoetharine (sodium bisulfite). JAMA. 1982; 248:2030 1. [IDIS 158261] [PubMed 7120631]



cc. Baker GJ, Collett P, Allen DH. Bronchospasm induced by metabisulphite containing foods and drugs. Med J Aust. 1981; 2:614 7. [IDIS 146240] [PubMed 7334982]



dd. Koepke JW, Selner JC, Dunhill AL. Presence of sulfur dioxide in commonly used bronchodilator solutions. J Allergy Clin Immunol. 1983; 72:504 8. [IDIS 178793] [PubMed 6630799]



ee. Food and Drug Administration. Sulfiting agents; labeling in drugs for human use: warning statement. [Docket No. 84N 0113] Fed Regist. 1985; 50:47558 63.



ff. Food and Drug Administration Center for Food Safety and Applied Nutrition. The reexamination of the GRAS status of sulfiting agents, January 1985. (Doc. No. 223-83-2020.) Bethesda, MD: FASEB Life Sciences Research Office.



More Hydroquinone resources


  • Hydroquinone Side Effects (in more detail)
  • Hydroquinone Use in Pregnancy & Breastfeeding
  • Hydroquinone Support Group
  • 2 Reviews for Hydroquinone - Add your own review/rating


  • Aclaro Concise Consumer Information (Cerner Multum)

  • Alustra MedFacts Consumer Leaflet (Wolters Kluwer)

  • Epiquin Micro Prescribing Information (FDA)

  • Esoterica Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Solaquin Forte Cream MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Hydroquinone with other medications


  • Dermatological Disorders